explore -WSS

explore

author：comprehensive 2025-09-30 15:16:51 - browse：421

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Carvykti CAR

WSS

Medicare Advantage beneficiaries sue Humana over algorithm use

Activists slam private health insurers over coverage restrictions

Hepatitis C has a cure — but many Americans still lack access to it

What does generative AI mean for health care? We asked experts

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

Malaria cases in Florida and Texas: Here’s what you need to know

Wikipedia

explore

focus

At least 13 dead in Texas as scorching temps continue

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

At least 13 dead in Texas as scorching temps continue

How to keep neuroscience’s past racism from being its future

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Wildfire smoke exposes gaps in outdoor worker protections

Supreme Court strikes down use of affirmative action

Medical leaders decry Supreme Court decision on affirmative action

Medicare details structure of new drug price negotiation program

Medicare drug price negotiation hasn't dried up venture capital

focus

Can sheer will power keep patients alive in their dying hours?

Violet CEO on training clinicians to promote more inclusive care

Bright Health sells Medicare Advantage business to Molina

What does generative AI mean for health care? We asked experts

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Activists slam private health insurers over coverage restrictions

hotspot

hotspot

knowledge

explore